Antivert and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Antivert (meclizine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Protonix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Diplopia when taking Antivert. It is created by eHealthMe based on reports of 3,935 people who have side effects when taking Antivert from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,428 drugs and 1,895 conditions by eHealthMe. Check the latest studies of Diplopia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

3,935 people reported to have side effects when taking Antivert.
Among them, 61 people (1.55%) have Diplopia.

Among these 61 people:

How long have people been on Antivert when they have Diplopia? *

What is the gender of people who have Diplopia when taking Antivert? *

female: 60.66 %
male: 39.34 %

What is the age of people who have Diplopia when taking Antivert? *

What are other drugs people take besides Antivert? *

What are other side effects people have besides Diplopia? *

Pain: 46 people, 75.41%
Pneumonia: 31 people, 50.82%
Vision Blurred: 31 people, 50.82%
Muscle Spasms (muscle contraction): 31 people, 50.82%
Urinary Tract Infection: 31 people, 50.82%
Arthropathy: 31 people, 50.82%
Joint Pain: 30 people, 49.18%
Fall: 28 people, 45.90%
Weakness: 28 people, 45.90%
Headache (pain in head): 28 people, 45.90%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 17 people, 27.87%
Pain: 15 people, 24.59%
High Blood Cholesterol: 14 people, 22.95%
High Blood Pressure: 13 people, 21.31%
Nosebleed (bleeding from nose): 12 people, 19.67%
Hypersensitivity: 12 people, 19.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 19.67%
Incontinence (lack of moderation or self-control): 12 people, 19.67%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 12 people, 19.67%
Blood Potassium Decreased: 12 people, 19.67%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Antivert:

Antivert (4,087 reports)

Diplopia treatments and more:

Diplopia (32,466 reports)

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,428 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,895 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride (the active ingredients of Antivert) and Antivert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.